Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.32 |
| ▸ | RAB9A | P51151 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | EDNRB | P24530 | 1/20 | 0.31 |
| ▸ | EDNRA | P25101 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | MET | P08581 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32681002 | 0.85 | MEN1 (0.34) | SMN1; SMN2RAB9AMAPTFFAR1KDM4E | |
| SCHEMBL32680956 | 0.84 | GCGR (0.39) | MAPTMEN1KMT2ATP53 | |
| SCHEMBL32680982 | 0.84 | EGFR (0.37) | SMN1; SMN2MAPTKDM4EALDH1A1GAA | |
| SCHEMBL32680905 | 0.83 | CRHR1 (0.35) | SMN1; SMN2RAB9AMAPTFFAR1KDM4E | |
| SCHEMBL32680802 | 0.82 | PTAFR (0.35) | SMN1; SMN2RAB9AMAPTKDM4EALDH1A1 | |
| SCHEMBL32680989 | 0.81 | CYP2A6 (0.44) | ALDH1A1S1PR1 | |
| SCHEMBL32680945 | 0.80 | MAPT (0.37) | SMN1; SMN2RAB9AMAPTEDNRBEDNRA | |
| SCHEMBL21364460 | 0.74 | MEN1 (0.39) | SMN1; SMN2RAB9AMAPTALDH1A1HTT | |
| SCHEMBL4755042 | 0.73 | ALDH1A1 (0.41) | SMN1; SMN2MAPTKDM4EALDH1A1KMT2A | |
| SCHEMBL32680994 | 0.71 | CASP3 (0.39) | SMN1; SMN2RAB9AMAPTFFAR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | PURDUE RESEARCH FOUNDATION (US) | 2026-03-05 | — | — | US | claimed |
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | PURDUE RESEARCH FOUNDATION (US) | 2026-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062607-A1 | TWO-DIMENSIONAL LATTICE CONFINED SINGLE-MOLECULE-LIKE AGGREGATES | BLM, MEF2D, SNCA | SMN1; SMN2 105/4885RAB9A 1357/4885MAPT 144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.